On Thursday, Pandora Media Inc (NYSE:P)’s shares inclined 1.11% to $14.15.
Pandora (P), the leading Internet radio service, declared that over 1 million listeners added Pandora’s “Mumford & Sons Live” station. Pandora partnered with the Grammy-winning Glassnote Records artist to livestream the band’s sold-out show at Maryland’s Merriweather Post Pavilion on June 10. The station also features a track-by-track archive of the show in addition to an exclusive video interview.
Pandora Media, Inc. provides Internet radio services in the United States. The company allows listeners to create up to 100 personalized stations to access free music and comedy catalogs, in addition to offers Pandora One, a paid subscription service to listeners. It also sells audio, display, and video advertising to advertisers for delivery on computer, mobile, and other connected device platforms.
Neuroderm Ltd (NASDAQ:NDRM)’s shares gained 7.63% to $18.63.
NeuroDerm Ltd. (NDRM), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, declared the pricing of its public offering of 3,934,520 shares of its ordinary shares at a price to the public of $17.00 per share, before underwriting discounts. All of the ordinary shares are being offered by NeuroDerm. In addition, NeuroDerm has granted the underwriters a 30-day option to purchase up to an additional 590,178 shares at the public offering price. NeuroDerm anticipates the total gross proceeds from the offering will be about $66.9 million. The company plans to use the net proceeds from the offering to fund its ND0612H and ND0612L product candidates through completion of its planned clinical trials and the regulatory approval process in the European Union and the United States, the clinical and regulatory development of its ND0701 product candidate, and general research and development of its product candidates, counting the development of the devices related to its product candidates.
Jefferies LLC and Cowen and Company, LLC are acting as the book-running managers for the offering and Raymond James & Associates, Inc. and Roth Capital Partners, LLC are acting as co-managers.
NeuroDerm Ltd., a clinical-stage pharmaceutical company, engages in developing products for the treatment of central nervous system (CNS) disorders. The company’s product candidates, which have accomplished Phase IIa clinical trial, comprise ND0612H for the treatment of patients with severe Parkinson’s disease; and ND0612L for the treatment of patients with moderate stage of Parkinson’s disease.
At the end of Thursday’s trade, Statoil ASA(ADR) (NYSE:STO)‘s shares surged 1.53% to $17.25.
Statoil ASA (ADR) (STO) has hit gas in the Gymir prospect in the Aasta Hansteen area together with its PL602 partners.
With the latest discovery, the company has struck a hat trick in the Aasta Hansteen area and has assisted in unlocking the full potential of the area.
The three discoveries – Snefrid Nord, Roald Rygg and Gymir – combined are estimated to hold total volumes of 75–120 million barrels of recoverable oil equivalent. This corresponds to around 1/3 of the recoverable volumes at Aasta Hansteen.
In order to enhance utilization of the infrastructure and extend the production plateau, the discoveries will now be further appraised for future ties in the Aasta Hansteen facilities.
Drilled by the Transocean Spitsbergen rig in the Gymir prospect, the well 6706/11-2, established a gross 70-meter gas column in the Nise Formation with good reservoir qualities.
Statoil ASA, an energy company, engages in the exploration, production, transportation, refining, and marketing of petroleum and petroleum-derived products in Norway and internationally. The company operates through Development and Production Norway; Development and Production International; Marketing, Processing and Renewable Energy; and Other segments.
Yum! Brands, Inc. (NYSE:YUM), ended its Thursday’s trading session with -0.74% loss, and closed at $88.24.
Yum! Brands, Inc. (YUM) still has plenty of growth potential in China.
The Louisville-based restaurant company, which comprises KFC Corp., Taco Bell Corp. and Pizza Hut Inc., has hailed itself as the industry leader in China. KFC has twice as many stores in China as McDonald’s Corp., according to a presentation at Yum Brands’ (NYSE: YUM) 2015 China Investors Conference this weekend.
Despite this, the company has only five stores per million people in China, contrast with 57 restaurants per million residents in the United States, the presentation states.
YUM Brands has focused its growth on cities, and about 15 million Chinese people migrate to cities each year. The Chinese urban population is expect to grow by 60 percent by 2020.
To stay competitive, Yum Brands is revamping its menus in China. With KFC in particular, the company has emphasized health and is focused on fewer, but stronger menu items.
YUM! Brands, Inc., together with its auxiliaries, operates quick service restaurants. It operates in five segments: YUM China, YUM India, the KFC Division, the Pizza Hut Division, and the Taco Bell Division. The company develops, operates, franchises, and licenses a system of restaurants, which prepare, package, and sell various food items. As of February 4, 2015, it operated about 41,000 restaurants in about 120 countries and territories primarily under the KFC, Pizza Hut, and Taco Bell brands, which specialize in chicken, pizza, and Mexican-style food categories.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
